Our industry is a cornerstone of Saudi Vision because we are making big investments in talent development alongside the public sector to ensure that we raise…
In Conversation
It is important to look at healthcare as an investment, rather than a burden on the public budget: an investment in the population, their health and…
The talent in Saudi Arabia is absolutely world-class; they are highly educated and extremely hard-working. They have a high sense of purpose, and are very engaged.…
The biggest opportunity [in MEA] is to help accelerate the diagnosis and treatment of patients, too many of whom fall through the gaps of healthcare coverage…
The ambitious mindset that the Saudi Arabia Vision 2030 sets out fits well with the mentality we are embracing at Novartis. I like to say that…
[R&D] is the gateway to successful production and competition in the marketplace. Without R&D, DEVA would not be where it is today
Bristol Myers Squibb has lent its full support to Saudi Arabia’s 2030 Strategic Vision, and we are happy to see that the pharma industry has been…
As a result of Turkey’s high-quality medical treatment, medical tourism is significantly increasing. Patients from all around the world, especially the Middle East, are coming to…
US investment decides where to go for periods of 7-10 years, so Turkey has to be ready so as not to miss the window of opportunity…
Every crisis creates an opportunity and I believe that COVID showed us the importance of investing in R&D and the pharma sector to bring innovation
We have leading products in diabetes, cardio, and fertility, neurology and are also very strong in oncology. It is not only about being number one in…
During the last 15 years, the public sector has built 13 new hospitals with the latest technology for 7,000 beds, and the private sector has not…
